<table width="95%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 3. Effect of Co-administered Drugs on the Pharmacokinetics of Atorvastatin</caption>
<col align="left" span="1" valign="top" width="40%"></col>
<col align="left" span="1" valign="top" width="30%"></col>
<col align="left" span="1" valign="top" width="15%"></col>
<col align="left" span="1" valign="top" width="15%"></col>
<tbody>
<tr>
<th colspan="1">Co-administered drug and dosing regimen</th>
<th colspan="3">Atorvastatin</th>
</tr>
<tr>
<th colspan="1"></th>
<th colspan="1">Dose (mg)</th>
<th colspan="1">Change in AUC<sup>&amp;</sup>
</th>
<th colspan="1">Change in Cmax<sup>&amp;</sup>
</th>
</tr>
<tr>
<td>
<sup>#</sup>Cyclosporine 5.2 mg/kg/day, stable dose </td>
<td>10 mg QD for 28 days</td>
<td>↑ 8.7 fold</td>
<td>↑10.7 fold</td>
</tr>
<tr>
<td>
<sup>#</sup>Tipranavir 500 mg BID/ritonavir 200 mg BID, 7 days</td>
<td>10 mg, SD</td>
<td>↑ 9.4 fold</td>
<td>↑ 8.6 fold</td>
</tr>
<tr>
<td>
<sup>#</sup>Telaprevir 750 mg q8h, 10 days</td>
<td>20 mg, SD</td>
<td>↑ 7.88 fold</td>
<td>↑ 10.6 fold</td>
</tr>
<tr>
<td>
<sup>#, ‡</sup>Saquinavir 400 mg BID/ ritonavir 400mg BID, 15 days</td>
<td>40 mg QD for 4 days</td>
<td>↑ 3.9 fold</td>
<td>↑ 4.3 fold</td>
</tr>
<tr>
<td>
<sup>#</sup>Clarithromycin 500 mg BID, 9 days</td>
<td>80 mg QD for 8 days</td>
<td>↑ 4.4 fold</td>
<td>↑ 5.4 fold</td>
</tr>
<tr>
<td>
<sup>#</sup>Darunavir 300 mg BID/ritonavir 100 mg BID, 9 days</td>
<td>10 mg QD for 4 days</td>
<td>↑ 3.4 fold</td>
<td>↑ 2.25 fold</td>
</tr>
<tr>
<td>
<sup>#</sup>Itraconazole 200 mg QD, 4 days </td>
<td>40 mg SD</td>
<td>↑ 3.3 fold</td>
<td>↑ 20% </td>
</tr>
<tr>
<td>
<sup>#</sup>Fosamprenavir 700 mg BID/ritonavir 100 mg BID, 14 days</td>
<td>10 mg QD for 4 days</td>
<td>↑ 2.53 fold </td>
<td>↑ 2.84 fold </td>
</tr>
<tr>
<td>
<sup>#</sup>Fosamprenavir 1400 mg BID, 14 days</td>
<td>10 mg QD for 4 days</td>
<td>↑ 2.3 fold </td>
<td>↑ 4.04 fold </td>
</tr>
<tr>
<td>
<sup>#</sup>Nelfinavir 1250 mg BID, 14 days</td>
<td>10 mg QD for 28 days</td>
<td>↑ 74% </td>
<td>↑ 2.2 fold </td>
</tr>
<tr>
<td>
<sup>#</sup>Grapefruit Juice, 240 mL QD <sup>*</sup>
</td>
<td>40 mg, SD</td>
<td>↑ 37%</td>
<td>↑ 16%</td>
</tr>
<tr>
<td>Diltiazem 240 mg QD, 28 days </td>
<td>40 mg, SD</td>
<td>↑ 51%</td>
<td>No change</td>
</tr>
<tr>
<td>Erythromycin 500 mg QID, 7 days </td>
<td>10 mg, SD</td>
<td>↑ 33%</td>
<td>↑ 38%</td>
</tr>
<tr>
<td>Amlodipine 10 mg, single dose </td>
<td>80 mg, SD</td>
<td>↑ 15%</td>
<td>↓ 12 %</td>
</tr>
<tr>
<td>Cimetidine 300 mg QD, 4 weeks </td>
<td>10 mg QD for 2 weeks</td>
<td>↓ Less than 1%</td>
<td>↓ 11%</td>
</tr>
<tr>
<td>Colestipol 10 mg BID, 28 weeks </td>
<td>40 mg QD for 28 weeks</td>
<td>Not determined</td>
<td>↓ 26%<sup>**</sup>
</td>
</tr>
<tr>
<td>Maalox TC® 30 mL QD, 17 days </td>
<td>10 mg QD for 15 days</td>
<td>↓ 33%</td>
<td>↓ 34%</td>
</tr>
<tr>
<td>Efavirenz 600 mg QD, 14 days </td>
<td>10 mg for 3 days</td>
<td>↓ 41%</td>
<td>↓ 1%</td>
</tr>
<tr>
<td>
<sup>#</sup>Rifampin 600 mg QD, 7 days (coadministered) <sup>†</sup>
</td>
<td>40 mg SD</td>
<td>↑ 30%</td>
<td>↑ 2.7 fold</td>
</tr>
<tr>
<td>
<sup>#</sup>Rifampin 600 mg QD, 5 days (doses separated) <sup>†</sup>
</td>
<td>40 mg SD</td>
<td>↓ 80%</td>
<td>↓ 40%</td>
</tr>
<tr>
<td>
<sup>#</sup>Gemfibrozil 600mg BID, 7 days </td>
<td>40mg SD </td>
<td>↑ 35%</td>
<td>↓ Less than 1%</td>
</tr>
<tr>
<td>
<sup>#</sup>Fenofibrate 160mg QD, 7 days</td>
<td>40mg SD       </td>
<td>↑ 3%</td>
<td>↑ 2%</td>
</tr>
</tbody>
</table>